Pyxis Oncology, Inc. (PYXS) Gross margin 2024–2025
Pyxis Oncology, Inc. (PYXS) gross margin by fiscal year — reported gross profit divided by reported revenue.
82.8%FY2025 · since FY2024: 97.1% → 82.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 82.8% | -14.3 pp |
| FY2024 | 97.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice